首页> 外国专利> HETEROMULTIMERA RECEPTORS TYPE I AND TYPE II PROTEINS OF THE TGF-BETA SUPERFAMILY

HETEROMULTIMERA RECEPTORS TYPE I AND TYPE II PROTEINS OF THE TGF-BETA SUPERFAMILY

机译:TGF-BETA超家族的I型和II型异多聚体受体

摘要

In some aspects, the invention provides soluble heteromeric polypeptide complexes comprising the extracellular domain of the type I serine / threonine kinase receptor proteins of the TGF-beta family and the extracellular domain of the type II serine / threonine kinase receptor proteins of the TGF-beta family. In some embodiments, the invention provides soluble polypeptide complexes comprising the extracellular domain of a type II receptor selected from ActRIIA, ActRIIB, TGFBRII, BMPRII, and MISRII. In some embodiments, the invention provides soluble polypeptide complexes comprising the extracellular domain of a type I receptor selected from ALK1, ALK2, ALK3, ALK4, ALK5, ALK6, and ALK7. Optionally, the soluble complex is a heterodimer. In some aspects, such soluble polypeptide complexes can be used to regulate (stimulate or inhibit) the growth of tissues or cells, including, for example, muscle, bone, cartilage, adipose tissue, nerve tissue, tumors, malignant cells and / or hematopoietic germ cells, including red blood cells . In some aspects, such soluble polypeptide complexes can be used to improve muscle formation, bone formation, hematopoiesis, metabolic parameters, and disorders associated with these tissues, cell networks, and endocrine systems.
机译:在一些方面,本发明提供了可溶性异聚多肽复合物,其包含TGF-β家族的I型丝氨酸/苏氨酸激酶受体蛋白的胞外域和TGF-β的II型丝氨酸/苏氨酸激酶受体蛋白的胞外域。家庭。在一些实施方案中,本发明提供了可溶性多肽复合物,其包含选自ActRIIA,ActRIIB,TGFBRII,BMPRII和MISRII的II型受体的胞外域。在一些实施方案中,本发明提供了包含选自ALK1,ALK2,ALK3,ALK4,ALK5,ALK6和ALK7的I型受体的胞外域的可溶性多肽复合物。任选地,可溶性复合物是异二聚体。在一些方面,这样的可溶性多肽复合物可用于调节(刺激或抑制)组织或细胞的生长,包括例如肌肉,骨骼,软骨,脂肪组织,神经组织,肿瘤,恶性细胞和/或造血细胞。生殖细胞,包括红细胞。在一些方面,此类可溶性多肽复合物可用于改善肌肉形成,骨形成,造血,代谢参数以及与这些组织,细胞网络和内分泌系统相关的疾病。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号